{
    "2020-05-12": [
        [
            {
                "time": "2020-05-13",
                "original_text": "恒瑞医药：公司销售费用率处于行业居中水平",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "销售费用率",
                        "行业水平"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-12",
                "original_text": "北向资金连续3日净流入，今日净买入恒瑞医药4.68亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "恒瑞医药"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-11",
                "original_text": "两融业务周报（20200504-20200508）",
                "features": {
                    "keywords": [
                        "两融业务",
                        "周报"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-10",
                "original_text": "【山证医药】医药行业周报：行业刚性需求凸显，建议关注恢复较快细分领域",
                "features": {
                    "keywords": [
                        "医药行业",
                        "刚性需求",
                        "细分领域"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-08",
                "original_text": "恒瑞医药：药品联合治疗晚期恶性肿瘤方案获准临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "临床试验",
                        "晚期恶性肿瘤"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-07",
                "original_text": "恒瑞医药澄清：受贿案件中部分证人是公司子公司员工",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "澄清",
                        "受贿案件"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-06",
                "original_text": "集采冲击！150亿市场扬子江、正大天晴、司立抢过评，造影剂龙头恒瑞急了？",
                "features": {
                    "keywords": [
                        "集采",
                        "恒瑞医药",
                        "造影剂",
                        "市场冲击"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}